| 2024-08-12 | -60.2% | earnings | Seeking Alpha | Neuronetics, Inc. (STIM) Q2 2024 Earnings Call Transcript |
| 2024-08-12 | -60.2% | earnings | Seeking Alpha | Neuronetics, Inc. 2024 Q2 - Results - Earnings Call Presentation |
| 2024-08-12 | -60.2% | legal | SEC EDGAR | STIM 8-K: 2.02 and (SEC Filing) |
| 2024-08-12 | -60.2% | legal | SEC EDGAR | STIM 8-K: 2.02, 7.01 (SEC Filing) |
| 2024-03-05 | +44.6% | legal | SEC EDGAR | STIM 8-K: 2.02 and (SEC Filing) |
| 2024-11-12 | -44.3% | earnings | Seeking Alpha | Neuronetics misses top-line and bottom-line estimates; initiates Q4 and updates FY24 outlook |
| 2024-11-12 | -44.3% | legal | SEC EDGAR | STIM 8-K: 2.02, 7.01 (SEC Filing) |
| 2021-08-03 | -40.1% | legal | SEC EDGAR | STIM 8-K: 2.02 and (SEC Filing) |
| 2024-05-07 | -32.1% | legal | SEC EDGAR | STIM 8-K: 2.02 and (SEC Filing) |
| 2021-05-04 | +31.7% | legal | SEC EDGAR | STIM 8-K: 2.02 and (SEC Filing) |
| 2026-01-06 | +28.1% | legal | SEC EDGAR | STIM 8-K: 5.02 and (SEC Filing) |
| 2026-01-06 | +28.1% | news | TipRanks | Neuronetics Grants Retention-Focused Incentive Awards to Executives - TipRanks |
| 2023-05-09 | +27.7% | legal | SEC EDGAR | STIM 8-K: 2.02 and (SEC Filing) |
| 2025-03-04 | +27.4% | earnings | Seeking Alpha | Neuronetics, Inc. (STIM) Q4 2024 Earnings Call Transcript |
| 2025-03-04 | +27.4% | earnings | Seeking Alpha | Neuronetics GAAP EPS of -$0.33 misses by $0.09, revenue of $22.49M beats by $3.51M |
| 2025-03-04 | +27.4% | legal | SEC EDGAR | STIM 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-03-04 | +27.4% | legal | SEC EDGAR | STIM 8-K: 5.02 (SEC Filing) |
| 2025-02-10 | +27.3% | legal | SEC EDGAR | STIM 8-K: 1.01, 8.01 (SEC Filing) |
| 2023-03-07 | -26.7% | legal | SEC EDGAR | STIM 8-K: 2.02 and (SEC Filing) |
| 2025-01-13 | +26.0% | legal | SEC EDGAR | STIM 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-03-18 | +25.3% | news | Stock Titan | Large Neuronetics (STIM) holder discloses 6,985,404-share position - Stock Titan |
| 2026-03-18 | +25.3% | news | Stock Titan | Large Neuronetics (STIM) insider purchase adds 531,000 shares at $1.16 - Stock Titan |
| 2021-10-12 | -23.1% | legal | SEC EDGAR | STIM 8-K: 2.02 and (SEC Filing) |
| 2024-03-06 | +21.8% | legal | SEC EDGAR | STIM 8-K: 5.02 (SEC Filing) |
| 2026-02-10 | +21.1% | earnings | Seeking Alpha | Neuronetics expects Q4 revenue of $41.8 million |
| 2026-02-10 | +21.1% | legal | SEC EDGAR | STIM 8-K: 2.02 and (SEC Filing) |
| 2026-02-10 | +21.1% | earnings | Stock Titan | Neuronetics lifts 2025 revenue 99%, books positive Q4 operating cash flow - Stock Titan |
| 2022-05-12 | +20.7% | legal | SEC EDGAR | STIM 8-K: 2.02 and (SEC Filing) |
| 2026-04-07 | -16.8% | news | GlobeNewswire | Neuronetics Comments on Letter from Pointillist Family Office |
| 2026-04-07 | -16.8% | news | Stock Titan | Neuronetics says board is open to shareholder talks on valuation - Stock Titan |
| 2026-01-07 | +16.3% | earnings | simplywall.st | There's No Escaping Neuronetics, Inc.'s (NASDAQ:STIM) Muted Revenues Despite A 25% Share Price Rise - simplywall.st |
| 2025-12-13 | +15.9% | news | simplywall.st | Would Neuronetics (NASDAQ:STIM) Be Better Off With Less Debt? - simplywall.st |
| 2025-11-06 | -15.8% | analyst | Yahoo Finance | Here's What Analysts Are Forecasting For Neuronetics, Inc. (NASDAQ:STIM) After Its Third-Quarter Results - Yahoo Finance |
| 2025-11-06 | -15.8% | analyst | simplywall.st | The Neuronetics, Inc. (NASDAQ:STIM) Third-Quarter Results Are Out And Analysts Have Published New Forecasts - simplywall.st |
| 2026-04-08 | -15.8% | news | Stock Titan | Major Neuronetics (STIM) holder presses Board to review TMS business - Stock Titan |
| 2026-04-08 | -15.8% | earnings | Cổng thông tin điện tử tỉnh Tây Ninh | Is Neuronetics (STIM) Stock trading above fair value | STIM Q4 2025 Earnings: Neuronetics Inc. beats EPS, no Q4 revenue reported - Partnership - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2026-04-03 | +15.3% | analyst | Simply Wall St. | How The Neuronetics (STIM) Story Is Shifting As Analysts Rework Valuation Assumptions |
| 2026-04-03 | +15.3% | analyst | Yahoo Finance | How The Neuronetics (STIM) Story Is Shifting As Analysts Rework Valuation Assumptions - Yahoo Finance |
| 2024-11-13 | +15.1% | earnings | Seeking Alpha | Neuronetics, Inc. (STIM) Q3 2024 Earnings Call Transcript |
| 2024-11-13 | +15.1% | legal | SEC EDGAR | STIM 8-K: 2.02 and (SEC Filing) |
| 2026-03-31 | +13.6% | news | Stock Titan | Jorey Chernett reports 14.1% Neuronetics (STIM) holding in 13D - Stock Titan |
| 2022-01-10 | +13.0% | legal | SEC EDGAR | STIM 8-K: 2.02 and (SEC Filing) |
| 2024-03-25 | +13.0% | legal | SEC EDGAR | STIM 8-K: 8.01 (SEC Filing) |
| 2026-03-24 | -12.7% | news | Stock Titan | Neuronetics (STIM) EVP Macan sells 16,005 shares to cover RSU tax - Stock Titan |
| 2026-03-24 | -12.7% | executive | Stock Titan | Neuronetics (STIM) CFO Pfanstiel sells 16,431 shares to cover tax withholding - Stock Titan |
| 2023-11-07 | +12.4% | legal | SEC EDGAR | STIM 8-K: 2.02 and (SEC Filing) |
| 2026-04-22 | +12.0% | M&A | Investing.com | Jorey Chernett acquires $309,000 in Neuronetics STIM stock - Investing.com |
| 2026-04-22 | +12.0% | earnings | MarketBeat | Insider Buying: Neuronetics (NASDAQ:STIM) Major Shareholder Buys 100,000 Shares of Stock - MarketBeat |
| 2026-04-22 | +12.0% | news | Stock Titan | Major holder at Neuronetics (NASDAQ: STIM) adds 200K shares - Stock Titan |
| 2026-02-25 | +11.5% | legal | SEC EDGAR | STIM 8-K: 5.02 (SEC Filing) |
| 2026-04-18 | +11.5% | analyst | Simply Wall St. | How The Neuronetics (STIM) Investment Story Is Reset As Analysts Rework Valuation Assumptions |
| 2026-04-18 | +11.5% | earnings | MarketBeat | Neuronetics (NASDAQ:STIM) Stock Rating Upgraded by Wall Street Zen - MarketBeat |
| 2026-04-18 | +11.5% | legal | Cổng thông tin điện tử tỉnh Tây Ninh | Neuronetics (STIM) Stock Cash Secured Put (In Focus) 2026-04-18 - High Reward Trade - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2025-02-03 | +11.3% | news | Yahoo Finance | Why Neuronetics Inc (STIM) Is Skyrocketing So Far In 2025 - Yahoo Finance |
| 2026-04-09 | -11.1% | news | Stock Titan | Neuronetics (NASDAQ: STIM) to vote on board, pay and 2026 equity plan - Stock Titan |
| 2026-03-04 | +10.9% | news | Stock Titan | STIM (NASDAQ: STIM) insider notifies sales; Macan sold 20,?32 shares - Stock Titan |
| 2023-10-03 | -10.1% | legal | SEC EDGAR | STIM 8-K: 1.01, 2.03, 7.01 (SEC Filing) |
| 2026-03-30 | +9.8% | legal | MT Newswires | Neuronetics Insider Bought Shares Worth $675,000, According to a Recent SEC Filing |
| 2026-03-30 | +9.8% | news | Investing.com | Chernett buys Neuronetics (STIM) shares worth $481,802 - Investing.com |
| 2026-03-30 | +9.8% | news | Investing.com | Chernett Jorey buys Neuronetics (STIM) shares worth $675,000 - Investing.com |
| 2026-03-30 | +9.8% | news | Stock Titan | [Form 4] Neuronetics, Inc. Insider Trading Activity - Stock Titan |
| 2026-02-11 | +9.8% | news | Benzinga | Neuronetics (STIM) Stock Rises 41% After Hours: What's Going On? - Benzinga |
| 2022-11-08 | +9.6% | legal | SEC EDGAR | STIM 8-K: 2.02 and (SEC Filing) |
| 2024-08-13 | +9.4% | legal | SEC EDGAR | STIM 8-K: 1.01, 3.02 (SEC Filing) |
| 2024-08-13 | +9.4% | M&A | Yahoo Finance | Neuronetics (STIM) Inks a New Merger Agreement With Greenbrook - Yahoo Finance |
| 2025-11-03 | +9.3% | earnings | Yahoo Finance | Neuronetics Inc (STIM) Q3 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance |
| 2025-11-18 | -9.2% | news | Benzinga | Top 3 Health Care Stocks Which Could Rescue Your Portfolio In November - Benzinga |
| 2025-08-05 | -9.2% | earnings | Seeking Alpha | Neuronetics adjusts 2025 gross margin guidance to 48%-50% as Greenbrook revenue mix rises |
| 2025-08-05 | -9.2% | earnings | Seeking Alpha | Neuronetics, Inc. (STIM) Q2 2025 Earnings Call Transcript |
| 2025-08-05 | -9.2% | earnings | Seeking Alpha | Neuronetics GAAP EPS of -$0.15 misses by $0.07, revenue of $38.11M beats by $1.17M |
| 2025-08-05 | -9.2% | legal | SEC EDGAR | STIM 8-K: 1.01, 2.02, 7.01 (SEC Filing) |
| 2026-02-27 | -8.7% | news | Investing.com | Macan, Neuronetics EVP, CLO and CS, sells $4.6k in STIM stock - Investing.com |
| 2025-02-07 | +8.7% | news | Seeking Alpha | Neuronetics shares drop as it prices $18M public offering of common stock |
| 2023-02-27 | +8.4% | legal | SEC EDGAR | STIM 8-K: 5.02 (SEC Filing) |
| 2025-10-21 | +7.8% | earnings | Quiver Quantitative | Neuronetics, Inc. Announces Q3 2025 Financial Results Release and Conference Call Schedule | STIM Stock News - Quiver Quantitative |
| 2021-07-02 | -7.5% | legal | SEC EDGAR | STIM 8-K: 5.02 (SEC Filing) |
| 2022-12-29 | +7.3% | legal | SEC EDGAR | STIM 8-K: 5.02, 5.03 (SEC Filing) |
| 2025-07-15 | -6.6% | executive | Seeking Alpha | Neuronetics appoints Steven Pfanstiel as chief financial officer |
| 2025-07-15 | -6.6% | legal | SEC EDGAR | STIM 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-01-22 | +6.5% | legal | SEC EDGAR | STIM 8-K: 1.01 and (SEC Filing) |
| 2026-03-20 | +6.3% | news | Investing.com | Chernett Jorey buys Neuronetics (STIM) shares worth $1.42 million - Investing.com |
| 2026-03-20 | +6.3% | news | Stock Titan | Neuronetics (NASDAQ: STIM) 10% holder buys 1,057,400 shares - Stock Titan |
| 2026-03-20 | +6.3% | news | Investing.com India | Chernett Jorey buys Neuronetics (STIM) shares worth $1.42 million By Investing.com - Investing.com India |
| 2022-03-08 | +6.2% | legal | SEC EDGAR | STIM 8-K: 2.02 and (SEC Filing) |
| 2025-04-01 | +6.1% | analyst | Quiver Quantitative | STIM | Neuronetics, Inc. Common Stock Analyst Forecasts - Quiver Quantitative |
| 2025-03-23 | -5.7% | news | Yahoo Finance | While private equity firms own 38% of Neuronetics, Inc. (NASDAQ:STIM), retail investors are its largest shareholders with 43% ownership - Yahoo Finance |
| 2025-11-12 | -5.7% | news | Stock Titan | Neuronetics (NASDAQ: STIM): TRICARE West covers NeuroStar TMS for ages 15+ in 26 states - Stock Titan |
| 2024-01-08 | -5.6% | legal | SEC EDGAR | STIM 8-K: 2.02 and (SEC Filing) |
| 2024-11-01 | +5.6% | legal | SEC EDGAR | STIM 8-K: 1.01 and (SEC Filing) |
| 2025-02-06 | -5.5% | expansion | Seeking Alpha | Neuronetics shares fall on launch of public offering of common stock |
| 2022-09-08 | +5.4% | analyst | TradingView | STIM Forecast — Price Target — Prediction for 2027 - TradingView |
| 2025-03-27 | -5.3% | earnings | Seeking Alpha | Neuronetics updates Q4 GAAP EPS loss to $0.34 |
| 2025-03-27 | -5.3% | legal | SEC EDGAR | STIM 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-04-23 | +5.3% | earnings | Cổng thông tin điện tử tỉnh Lào Cai | Is Neuronetics (STIM) stock worth watching today | Q4 2025: Earnings Beat Estimates - Real Time Stock Idea Network - Cổng thông tin điện tử tỉnh Lào Cai |
| 2022-02-22 | +5.3% | legal | SEC EDGAR | STIM 8-K: 1.01, 2.03, 7.01 (SEC Filing) |
| 2025-10-10 | -4.9% | news | TradingKey | STIM|Neuronetics Inc|Price:1.670|Chg%:-0.02 - TradingKey |
| 2025-11-21 | -4.8% | news | 富途牛牛 | Neuronetics, Inc.'s (NASDAQ:STIM) 36% Loss Last Week Hit Both Individual Investors Who Own 32% as Well as Institutions - 富途牛牛 |
| 2026-03-02 | -4.4% | legal | SEC EDGAR | STIM 8-K: 1.01 and (SEC Filing) |
| 2025-04-24 | +4.1% | news | Stock Titan | STIM Stock Price, News & Analysis - Stock Titan |
| 2026-03-15 | +4.0% | news | Seeking Alpha | Quant snapshot: Micron, Babcock & Wilcox lead strong buys as Fold Holdings, Alvotech lag |
| 2026-04-01 | +4.0% | news | Stock Titan | Madryn funds shift 674,624 Neuronetics (STIM) shares between vehicles - Stock Titan |
| 2024-12-10 | +3.9% | legal | SEC EDGAR | STIM 8-K: 1.01, 2.01, 3.02, 5.02, 5.03, 8.01 (SEC Filing) |
| 2021-10-20 | +3.7% | legal | SEC EDGAR | STIM 8-K: 2.02 and (SEC Filing) |
| 2026-04-13 | +3.7% | news | GlobeNewswire | Optum/United Healthcare/United Behavioral Health Expands NeuroStar® TMS Coverage to Include Psychiatric Mental Health Nurse Practitioners |
| 2026-04-13 | +3.7% | news | Stock Titan | 34.8 million covered lives gain broader access to non-drug depression care - Stock Titan |
| 2026-04-06 | +3.4% | earnings | MT Newswires | Neuronetics Announces CFO Exit, Reaffirms Financial Guidance |
| 2026-04-06 | +3.4% | news | MT Newswires | Neuronetics' Largest Shareholder Urges Review of Strategic Alternatives |
| 2026-04-06 | +3.4% | executive | GlobeNewswire | Neuronetics Announces Chief Financial Officer Transition |
| 2026-04-06 | +3.4% | news | PR Newswire | Largest Independent Shareholder of Neuronetics, Inc., Jorey Chernett, Calls for Immediate and Comprehensive Review of Strategic Alternatives, Including Sale of TMS Business |
| 2026-04-06 | +3.4% | executive | Seeking Alpha | Neuronetics CFO Steven Pfanstiel to depart; company begins search for successor |
| 2026-04-06 | +3.4% | legal | SEC EDGAR | STIM 8-K: 1.01, 2.05, 5.02, 7.01 (SEC Filing) |
| 2026-04-06 | +3.4% | news | Stock Titan | Largest Independent Shareholder of Neuronetics, Inc., Jorey Chernett, Calls for Immediate and Comprehensive Review of Strategic Alternatives, Including Sale of TMS Business - Stock Titan |
| 2026-04-06 | +3.4% | executive | Stock Titan | Neuronetics sticks with 2026 outlook as finance chief plans exit - Stock Titan |
| 2026-04-06 | +3.4% | executive | Stock Titan | CFO exit and cost cuts at Neuronetics (NASDAQ: STIM) 2026 - Stock Titan |
| 2026-04-06 | +3.4% | news | Xã Thanh Hà | Is Neuronetics (STIM) Stock Expanding | Price at $1.78, Up 17.11% - Open Stock Signal Network - Xã Thanh Hà |
| 2026-03-03 | +3.3% | earnings | Stock Titan | Neuronetics sets Q4 2025 financial results call for March 17 - Stock Titan |
| 2022-08-26 | -3.2% | legal | SEC EDGAR | STIM 8-K: 5.02 (SEC Filing) |
| 2025-09-18 | -3.1% | news | DirectorsTalk Interviews | Neuronetics, Inc. (STIM) Stock Analysis: Unpacking The 128% Upside Potential - DirectorsTalk Interviews |
| 2025-03-30 | -3.1% | legal | Seeking Alpha | Neuronetics: Explosive Growth Poised To Soar On FDA Breakthroughs |
| 2025-03-29 | -3.1% | legal | Seeking Alpha | Neuronetics: Explosive Growth Poised To Soar On FDA Breakthroughs (NASDAQ:STIM) - Seeking Alpha |
| 2025-05-15 | -3.0% | executive | simplywall.st | Why We Think Neuronetics, Inc.'s (NASDAQ:STIM) CEO Compensation Is Not Excessive At All - simplywall.st |
| 2023-05-25 | +2.9% | earnings | Seeking Alpha | Neuronetics Q1 Earnings: Profit Potential Remains Uncertain (NASDAQ:STIM) - Seeking Alpha |
| 2024-07-30 | -2.7% | legal | SEC EDGAR | STIM 8-K: 1.01, 1.02, 2.03 (SEC Filing) |
| 2023-08-08 | -2.6% | legal | SEC EDGAR | STIM 8-K: 2.02 and (SEC Filing) |
| 2026-03-27 | -2.5% | news | Stock Titan | Neuronetics (STIM) 10% owner Jorey Chernett buys 150,000 shares - Stock Titan |
| 2023-01-09 | -2.5% | legal | SEC EDGAR | STIM 8-K: 2.02 and (SEC Filing) |
| 2025-06-02 | -2.4% | news | Seeking Alpha | Neuronetics to join Russell 3000 and Russell 2000 indexes |
| 2022-08-03 | +2.3% | analyst | Zacks Investment Research | What is the current Price Target and Forecast for Neuronetics (STIM) - Zacks Investment Research |
| 2024-08-05 | +2.0% | news | Stock Titan | Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Stock Titan |
| 2026-04-12 | +2.0% | legal | Stock Titan | [EFFECT] Neuronetics, Inc. SEC Filing - Stock Titan |
| 2023-04-04 | -1.8% | legal | SEC EDGAR | STIM 8-K: 1.01, 2.03, 7.01 (SEC Filing) |
| 2025-05-06 | +1.8% | earnings | Seeking Alpha | Neuronetics, Inc. 2025 Q1 - Results - Earnings Call Presentation |
| 2025-05-06 | +1.8% | earnings | Seeking Alpha | Neuronetics, Inc. (STIM) Q1 2025 Earnings Call Transcript |
| 2025-05-06 | +1.8% | earnings | Seeking Alpha | Neuronetics reports mixed Q1 results; initiates Q2 and reaffirms FY25 outlook |
| 2025-05-06 | +1.8% | legal | SEC EDGAR | STIM 8-K: 2.02, 5.02, 7.01 (SEC Filing) |
| 2025-05-06 | +1.8% | earnings | Stock Titan | Neuronetics Earnings Reveal Massive 84% Growth as Mental Health Treatment Network Expands - Stock Titan |
| 2026-01-28 | -1.6% | news | simplywall.st | Following a 26% decline over last year, recent gains may please Neuronetics, Inc. (NASDAQ:STIM) institutional owners - simplywall.st |
| 2025-05-18 | +1.5% | news | Intellectia AI | STIM Forecast — Price Prediction for 2026. Should I Buy STIM? - Intellectia AI |
| 2024-10-04 | +1.3% | M&A | Seeking Alpha | Neuronetics and Greenbrook TMS get interim order for merger |
| 2024-03-26 | +1.3% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2022-05-05 | -1.0% | legal | SEC EDGAR | STIM 8-K: 1.01 and (SEC Filing) |
| 2021-08-06 | +0.9% | legal | SEC EDGAR | STIM 8-K: 5.02, 7.01 (SEC Filing) |
| 2021-11-09 | +0.6% | legal | SEC EDGAR | STIM 8-K: 2.02 and (SEC Filing) |
| 2022-08-02 | +0.5% | legal | SEC EDGAR | STIM 8-K: 2.02 and (SEC Filing) |
| 2021-10-05 | -0.5% | legal | SEC EDGAR | STIM 8-K: 1.01 and (SEC Filing) |
| 2025-12-04 | +0.5% | legal | DirectorsTalk Interviews | Neuronetics, Inc. (STIM) Stock Analysis: Exploring a 385% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews |
| 2024-03-28 | +0.4% | legal | SEC EDGAR | STIM 8-K: 5.02 (SEC Filing) |
| 2026-03-17 | +0.4% | earnings | Seeking Alpha | Neuronetics outlines >9% 2026 revenue growth target while piloting new TMS models and preparing for Compass therapy launch |
| 2026-03-17 | +0.4% | earnings | Seeking Alpha | Neuronetics, Inc. (STIM) Q4 2025 Earnings Call Transcript |
| 2026-03-17 | +0.4% | earnings | Seeking Alpha | Neuronetics GAAP EPS of -$0.10 beats by $0.01, revenue of $41.78M beats by $0.94M |
| 2026-03-17 | +0.4% | executive | Seeking Alpha | Neuronetics appoints Dan Reuvers as chief executive officer |
| 2026-03-17 | +0.4% | legal | SEC EDGAR | STIM 8-K: 2.02, 5.02, 7.01 (SEC Filing) |
| 2026-03-17 | +0.4% | executive | Stock Titan | Mental-health device firm Neuronetics brings in growth-focused CEO - Stock Titan |
| 2026-03-17 | +0.4% | earnings | Stock Titan | Mental health firm Neuronetics doubles revenue as clinics surge, new CEO named - Stock Titan |
| 2026-03-17 | +0.4% | news | Stock Titan | Parian Ultreia reports 7.0% stake in Neuronetics (NASDAQ: STIM) — 4.84M shares - Stock Titan |
| 2026-03-17 | +0.4% | earnings | Stock Titan | Neuronetics (NASDAQ: STIM) doubles 2025 revenue, narrows loss and hires new CEO - Stock Titan |
| 2026-03-23 | -0.4% | earnings | Seeking Alpha | Neuronetics: Highly Speculative, But Revenue Growth Could Drive The Stock Higher |
| 2026-03-23 | -0.4% | earnings | Seeking Alpha | Neuronetics: Highly Speculative, But Revenue Growth Could Drive The Stock Higher (STIM) - Seeking Alpha |
| 2026-03-23 | -0.4% | news | Stock Titan | Major Neuronetics (NASDAQ: STIM) holder adds 169K shares - Stock Titan |
| 2026-04-21 | +0.3% | analyst | GlobeNewswire | Neuronetics to Report First Quarter 2026 Financial and Operating Results and Host Conference Call |
| 2026-04-21 | +0.3% | earnings | Stock Titan | Neuronetics will post quarterly results before the market opens May 5 - Stock Titan |
| 2026-04-21 | +0.3% | news | Cổng thông tin điện tử Tỉnh Sơn La | Neuronetics (STIM) Stock: Underpriced? (+11.27%) 2026-04-20 - Institutional Buying - Cổng thông tin điện tử Tỉnh Sơn La |
| 2025-11-04 | -0.2% | earnings | Seeking Alpha | Neuronetics targets $40M–$43M Q4 revenue as SPRAVATO mix drives full-year outlook |
| 2025-11-04 | -0.2% | earnings | Seeking Alpha | Neuronetics, Inc. (STIM) Q3 2025 Earnings Call Transcript |
| 2025-11-04 | -0.2% | earnings | Seeking Alpha | Neuronetics GAAP EPS of -$0.13 in-line, revenue of $37.3M misses by $0.55M |
| 2025-11-04 | -0.2% | legal | SEC EDGAR | STIM 8-K: 2.02, 5.02, 7.01 (SEC Filing) |
| 2025-11-04 | -0.2% | earnings | Yahoo Finance | Neuronetics Inc (STIM) Q3 2025 Earnings Call Highlights: Revenue Surges Amid Strategic Acquisitions - Yahoo Finance |
| 2025-11-04 | -0.2% | earnings | Yahoo Finance | Neuronetics (STIM) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance |
| 2025-04-30 | -0.1% | news | Yahoo Finance | Why Neuronetics, Inc. (STIM) is Surging in 2025 - Yahoo Finance |
| 2022-02-28 | -0.0% | legal | SEC EDGAR | STIM 8-K: 5.02 (SEC Filing) |
| 2025-12-25 | +0.0% | legal | DirectorsTalk Interviews | Neuronetics, Inc. (STIM) Stock Analysis: Exploring a 357.75% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews |